Ten tips in lupus nephritis management

Area of Science:

• Nephrology
• Immunology
• Internal Medicine

Background:

• Lupus nephritis is a severe form of glomerulonephritis and a primary cause of kidney failure in young adults.
• Untreated lupus nephritis can rapidly destroy nephrons, leading to acute kidney injury and long-term kidney failure.
• Significant advancements in clinical management over the past two decades have improved patient outcomes.

Purpose of the Study:

• To review the current landscape of lupus nephritis treatment.
• To highlight the impact of new therapeutic options on patient care.
• To emphasize the importance of personalized treatment strategies in managing lupus nephritis.

Main Methods:

• Review of current clinical management strategies for lupus nephritis.
• Discussion of established and emerging immunosuppressive therapies.
• Analysis of the role of novel agents like belimumab and voclosporin.
• Consideration of off-label use of medications such as tacrolimus.

Main Results:

• Mycophenolate has become a standard immunosuppressive therapy, enhancing treatment safety, convenience, and quality of life.
• New approvals for belimumab and voclosporin offer additional effective treatment options.
• Tacrolimus is approved in Japan and widely used off-label globally.
• The expanding therapeutic arsenal presents challenges in selecting optimal treatment regimens.

Conclusions:

• Effective therapies exist to reverse acute kidney injury and prevent kidney failure in lupus nephritis.
• Personalized treatment approaches, considering individual patient characteristics and risk profiles, are essential.
• A holistic, long-term perspective is necessary to achieve favorable clinical outcomes in lupus nephritis management.